Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel Chemotherapy
Status:
Recruiting
Trial end date:
2029-01-01
Target enrollment:
Participant gender:
Summary
Vulvar cancer is a rare malignancy. Surgery is the treatment of choice, but frequently causes
invalidating and chronic postoperative morbidity, especially in patients with high stage
disease. Theoretically, downstaging with neo adjuvant chemotherapy could shrink the tumour,
making surgical treatment less extensive thereby diminishing the chance for morbidity.